Vanguard Group Inc Rapt Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RAPT
# of Institutions
96Shares Held
111MCall Options Held
41.3KPut Options Held
100-
Orbimed Advisors LLC San Diego, CA13.1MShares$107 Million0.5% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$107 Million3.85% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$102 Million8.35% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$96 Million0.24% of portfolio
-
Bvf Inc San Francisco, CA9.24MShares$75.4 Million0.5% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $242M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...